Mangaluru | 3-year-old child crushed to death under speeding car

Bengaluru, May 5: A 62-year-old woman from Vijayapura succumbed to coronavirus infection on Tuesday, taking the COVID-19 death toll in Karnataka to 28, a health official said.

The state has registered eight more COVID-19 cases in the past 19 hours, increasing the count of such cases to 659, the official added.

"Positive case 640, 62-year-old female resident of Vijayapura died on Tuesday due to cardiac arrest," the health official said.

Admitted to a designated hospital''s ICU on Sunday, the woman was also suffering from Chronic Obstructive Pulmonary Disease (COPD), Bronchial Asthma (BA) and complained of breathlessness.

Among the eight fresh cases that emerged in the state, four were contacts of earlier cases, two with Influenza Like Illness (ILI) and one with travel history to Uttarakhand.

The health department is also tracing the contact history of a 30-year-old woman from Bengaluru Urban.

Incidentally, no new cases emerged from Davangere as 22 cases rocked the district on Monday.

Among the new cases, Bengaluru Urban contributed 3, followed by Bagalkote, 2, Ballari, Dakshina Kannada and Bhatkal in Uttara Kannada, 1 each.

Of the new cases, six are men and two women.

Bengaluru, Feb 17: Union Finance Minister Nirmala Sitharaman on Monday assured that the Centre is committed to stand by its promise of providing Rs 18,600 crore Bengaluru suburban Rail project.

Addressing a press conference after a post-budget interactive session with the representatives of the various trade bodies, industry leaders and others here, she said that the union cabinet has already given its clearance for the long-pending project.

Informing that the central government will have 20 per cent of its capital share in the project followed by another 20 per cent share from the state government, she said "beside this, the union government will stand for a sovereign guarantee for the rest of the 60 percent share, which can be raised through loans from external agencies".

New Delhi, Jun 13: Loss of smell or taste has been added to the list of COVID-19 symptoms, according to the revised clinical management protocols released by the Union Health Ministry on Saturday.

The ministry said that coronavirus-infected patients reporting to various COVID-19 treatment facilities have been reporting symptoms like fever, cough, fatigue, shortness of breath, expectoration, myalgia, rhinorrhea, sore throat and diarrhea.

They have also complained of loss of smell (anosmia) or loss of taste (ageusia) preceding the onset of respiratory symptoms.

Older people and immune-suppressed patients in particular may present with atypical symptoms such as fatigue, reduced alertness, reduced mobility, diarrhoea, loss of appetite, delirium, and absence of fever, the ministry said.

Children might not have reported fever or cough as frequently as adults.

The US's national public health institute, the Centers for Disease Control and Prevention (CDC), had in early May incorporated "a new loss of taste or smell" in the list of COVID-19 symptoms.

According to the data from Integrated Health Information Platform and Integrated Disease Surveillance Programme, portal case investigation forms for COVID 19 (n=15,366), the details on the signs and symptoms reported are (as on June 11), fever (27 per cent), cough (21 pc), sore throat (10 pc), breathlessness (8 pc), Weakness (7 pc), running nose (3pc ) and others 24 pc.

According to the health ministry, people infected by the novel coronavirus are the main source of infection.

Direct person-to-person transmission occurs through close contact, mainly through respiratory droplets that are released when the infected person coughs, sneezes, or talks.

These droplets may also land on surfaces, where the virus remains viable. Infection can also occur if a person touches an infected surface and then touches his or her eyes, nose, or mouth.

The median incubation period is 5.1 days (range 2–14 days). The precise interval during which an individual with COVID-19 is infectious is uncertain.

As per the current evidence, the period of infectivity starts 2 days prior to onset of symptoms and lasts up to 8 days.

The extent and role played by pre-clinical/ asymptomatic infections in transmission still remain under investigation.